Medicine shortages
Our work to highlight how medicine shortages affect patient care, the pressures on pharmacy teams, and recommendations to inform action.


World Patient Safety Day (WPSD) 2026
This year’s World Patient Safety Day theme focuses on safe and effective care for people living with noncommunicable diseases (NCDs), under the slogan ‘Safe care for life!’.

RCPharm annual conference 2026
Bringing together pharmacists and pharmaceutical scientists from across the UK and beyond, this will be our first Annual Conference as the new Royal College.
News
The latest news and updates from Royal College of Pharmacy.
-
Professor Ryan Donnelly awarded 2024 RPS Harrison Medal
This news story was published when the organisation was the Royal Pharmaceutical Society. We’re pleased to announce that Professor Ryan Donnelly has been awarded the RPS Harrison Memorial Medal for 2024 for his outstanding contribution to advancing pharmaceutical science. The medal is awarded every two years, in memory of the distinguished pharmaceutical chemist Col EF Harrison. Professor Ryan Donnelly is Chair in Pharmaceutical Technology at Queen’s University Belfast’s School of Pharmacy and Director of Research. A registered pharmacist, his expertise lies in developing advanced polymeric drug delivery systems for transdermal and intradermal drug delivery, aimed at improving patient outcomes. Collaborating with major pharmaceutical companies, he is developing a range of novel microneedle technologies. His work has attracted over £30m in funding and he has authored more than 1,000 peer-reviewed publications, including patent applications, textbooks, book chapters and full papers. He also leads a diverse research team of 50 individuals from 15 different countries and has been an invited speaker at numerous national and international conferences. His contributions have earned him prestigious awards, including the International Association for Pharmaceutical Technology Research Award for Outstanding Achievements in the Pharmaceutical Sciences (2024) and the Kydonieus Foundation Transdermal Delivery Award (2024). Professor Donnelly also won the European Journal of Pharmaceutics and Biopharmaceutics Most Cited Paper Award in 2023, Visit Belfast’s Ambassador Award for Life and Health Sciences in 2022, and many more throughout his career. As Europe/Africa Editor of Drug Delivery and Translational Research, Professor Donnelly continues to shape the field with his groundbreaking research and commitment to pharmaceutical science. Professor Donnelly said: “I am delighted to receive this great honour from RPS. As a pharmacist, my work has always focused on harnessing the pharmaceutical sciences to develop drug and vaccine delivery systems that can enhance therapeutic outcomes for patients. That these efforts have been recognised by such a prestigious award emphasises the importance of the application of scientific knowledge by the pharmacy profession.” Professor Parastou Donyai, RPS Chief Scientist said: “It is a real pleasure to announce Professor Ryan Donnelly as the 2024 RPS Harrison Medal winner. Professor Donnelly is a world leader in the field of drug delivery. His novel inventions have the potential for genuine impact, and his publication record, substantial research funding, and investment in developing others attest to his authority and distinction. Professor Donnelly is a credit to pharmaceutical science and the whole of the profession of pharmacy.” More on the Harrison Memorial Medal. Read more RCPharm news stories
-
His Majesty The King becomes new Patron of RPS
This news story was published when the organisation was the Royal Pharmaceutical Society. We are proud to announce His Majesty The King has agreed to become the new Patron of Royal Pharmaceutical Society (RPS). Buckingham Palace confirmed the news to mark the first anniversary of the Coronation of His Majesty The King and Her Majesty The Queen. It follows a thorough analysis of over 1,000 Patronages of The late Queen, The former Prince of Wales and The former Duchess of Cornwall. We have a long association with the Royal Family through The late Queen, who was Patron of RPS from 1953 until her death in 2022. Her father, George VI, was Patron of RPS from 1937-1952. Claire Anderson, president of RPS, said: “We are hugely proud that His Majesty The King has chosen to be our patron, following in the footsteps of The late Queen and her father, George VI. We are grateful to the Royal Family for their ongoing support.” Paul Bennett, chief executive of the RPS, said: “It is an honour to have His Majesty The King as our new Royal Patron. We look forward to continuing our work to highlight the vital contribution pharmacy teams make to patient care across Great Britain with the patronage of His Majesty.” Find out more about the history of RPS. Read more RCPharm news stories.
-
Prescription charge price hike harms patients, says RPS
This news story was published when the organisation was the Royal Pharmaceutical Society. Responding to the news that prescription charges in England will rise from £9.65 per item to £9.90 from 1 May 2024, and the 12-month Prescription Prepayment Certificate will also increase from £111.60 to £114.50, Tase Oputu, Chair of the Royal Pharmaceutical Society (RPS) in England, said: "Amid an ongoing cost of living crisis, the rise in prescription charges in England will hit working people on low incomes the hardest. “Every day pharmacists are asked by patients who are unable to afford all the items in their prescription which ones they could 'do without'. Patients shouldn’t have to make choices which involve rationing their medicines. No one should face a financial barrier to getting medicines which a health professional has prescribed as necessary. “The consequences of the relentless rise in prescription charges are well-known. If you can’t afford your medicines, your condition can worsen which leads to poor health, lost productivity and increases the risk of hospital admission, piling pressure on the NHS. “Prescriptions are free in Scotland, Wales and Northern Ireland. If they were free in England too then no one would have to worry about payment decisions affecting their health. “In a general election year, I hope that political parties can commit to properly reviewing this complex and unjust system. It is high time this stealth tax was abolished.” A recent survey of pharmacists by RPS and the Pharmacists' Defence Association showed that more than one-third of pharmacists (35%) said they have seen an increase in patients declining prescriptions in the past 12 months. The vast majority of respondents (97%) have seen cases where patients decline some of the medicines on a prescription owing to cost, one-quarter (26%) of whom said they saw this often. Prescription charges are one of the key issues in our general election manifesto. Find out how you can support the campaign at www.rpharms.com/manifesto. Read more RCPharm news stories.
-
New report emphasises importance of research in pharmacy practice
This news story was published when the organisation was the Royal Pharmaceutical Society. The Royal Pharmaceutical Society welcomes the release of NHS England's report on the involvement of pharmacy professionals in research. The report proposes the implementation of a clinical academic training pathway for pharmacy professionals by 2030. RPS President, Professor Claire Anderson, along with Joseph Oakley, Associate Director for Assessment and Credentialing, and Professor Parastou Donyai, RPS Chief Scientist, participated in the working group responsible for developing the report. RPS President, Claire Anderson, said: “The RPS was delighted to contribute a co-chair and have representation on the short-life working group that produced the report. We wholeheartedly welcome its recommendations. Research is an essential pillar of professional practice, driving continued professional innovation and advancement in care for patients. “The RPS is committed to enhancing pharmacists’ research capabilities. Research is a common domain across the RPS post-registration curricula due to its importance for professional innovation and advancing patient care. We recently worked with NIHR to create e-learning modules for pharmacists starting their research journeys, along with support services and guidance for members. “Professional engagement with research, supported by a network of clinical academics, is vital for the profession’s growth; pharmacists are uniquely placed within the healthcare system to drive forward the evidence base on the safe and effective use of medicines. The report’s suggestion to embed RPS curricula frameworks into pharmacists’ job descriptions by 2026 aligns with our mission to integrate research activities across all pharmacy sectors. This initiative will grow a cohort of research-engaged pharmacists ready to lead the pharmacy research agenda. “Recognising pharmacists’ challenges in balancing research amidst busy frontline roles, we advocate for protected learning time, as outlined in our policy and echoed by the report. Adequate funding is crucial to overcoming these barriers and delivering the report’s vision.” Read more RCPharm news.
-
Annual RPS Workforce Wellbeing Survey results
This news story was published when the organisation was the Royal Pharmaceutical Society. The Royal Pharmaceutical Society has revealed the results of its fifth annual workforce wellbeing survey, in partnership with the profession’s charity, Pharmacist Support, shedding light on the mental health challenges faced by pharmacists. At a time when pharmacists are increasingly being asked to deliver transformational change in the face of significant workplace pressures, the survey underscores the urgent need for better support systems to combat burnout and promote wellbeing at work. The results show a worrying 86% of pharmacists are at high risk of burnout, emphasising the importance of addressing the underlying factors contributing to poor mental health and wellbeing. Top factors attributed to burnout include inadequate staffing (69%), lack of work-life balance (52%), insufficient protected learning time (50%), absence of colleague or senior support (46%), and long working hours (42%). Overall, 61% of respondents reported not being offered sufficient protected learning time to focus on their professional development and learning needs, despite the drive across pharmacy to provide more clinical services. The survey also exposes the distressing trend of workplace abuse, with 41% of pharmacists reporting verbal abuse primarily from the public, and 25% from colleagues or managers. Shockingly, 7% of respondents reported experiencing physical abuse in the workplace. RPS and Pharmacist Support will convene a roundtable at the end of February to review the latest findings with the NHS, professional bodies, employers, trade unions, education and regulators. Professor Claire Anderson, RPS President, said: “The survey results demonstrate the human cost of coping with the relentless workplace pressures that pharmacists and trainees experience daily. The solutions require collaborative efforts from governments, employers and the NHS to create more supportive and fulfilling work environments. “As more pharmacists take on prescribing roles, the need for protected learning time becomes paramount. Without it, ambitions to expand prescribing services will be frustrated. A significant increase in learning opportunities for prescribers, and in workplace supervision capacity for designated prescribing practitioners, is essential. “No one should have to face abuse in the workplace. Such behaviour undermines the well-being of individuals and compromises the quality of care provided to patients.” Chief Executive of Pharmacist Support, Danielle Hunt said: "This annual joint workforce wellbeing survey is such an important piece of work which helps us to continue to highlight the ongoing issues impacting individuals within the pharmacy profession. This year’s results are yet another stark reminder of the urgent need for action to address the mental health challenges faced by pharmacists. It is imperative that we use this valuable information to inform concrete steps towards creating more supportive and sustainable work environments within the pharmacy profession. “The survey is an invaluable source of data that can inform necessary action. Informed by the results of previous year’s survey findings the charity has developed and launched a new course for pharmacy managers and leaders entitled ‘Embracing a Workplace Wellbeing Culture’. We recognised the need to move the conversation beyond individual mental health and broaden the focus of our work to supporting positive workplace culture. “Chairing the roundtable on wellbeing, hosted in partnership with the RPS and attended by representatives from the NHS, professional bodies, employers, trade unions, education and regulators, is part of our ongoing commitment to supporting meaningful dialogue and action to improve the working conditions and wellbeing of pharmacy professionals. Together with our partners, we are committed to championing initiatives that promote wellbeing and combat burnout, ensuring that pharmacists can thrive in their roles and continue to provide high-quality care to their patients. Find out more about our survey results and our work on workforce wellbeing. Read more RCPharm news stories

We are the Royal College of Pharmacy, the professional leadership body for pharmacists and pharmaceutical scientists. We exist to advance the safe and effective use of medicines, drive excellence in patient care and support pharmacists to deliver the highest standards of practice.
As the third largest workforce in healthcare, pharmacy plays a vital role in the health system, and as experts in medicines, pharmacists and their teams are central to patient care and public health. Our mission is to put pharmacy at the forefront of patient care, advancing the safe and effective use of medicines to the benefit of patients and the public.


Have any questions or comments on the new Royal College website?
Please visit our support page or email [email protected]

RCPharm Professional support
One-to-one support – every weekday, 9am until 5pm
Call 0207 572 2737 to speak to a member of our support team, or you can email us using the link below.
Our one-to-one support service is exclusively for RCPharm members.






